Track topics on Twitter Track topics that are important to you
Self-monitoring of blood glucose (SMBG) provided no clinical benefit to patients with type 2 diabetes not treated with insulin according to a recent trial published in JAMA Internal Medicine. Clinicians should consider each patient’s clinical situation before recommending home glucose monitoring, the authors advised.
Original Article: Home Monitoring Doesn’t Help Glycemic ControlNEXT ARTICLE
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...